This results in reduced binding of NFκB by its cytoplasmic inhibitor IκB, leading to increased translocation of NFκB to the nucleus and an increase in the expression of proinflammatory genes by HD myeloid cells (10). This evidence concerns the gene NFKB1 and Huntington disease.